+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounding for cancer in companion animals: therapeutic options and case reports



Compounding for cancer in companion animals: therapeutic options and case reports



International Journal of Pharmaceutical Compounding 13(1): 42-49



Americans spend more than $20 billion per year on health care for their pets which are considered by many owners to be members of the family. In the past, the diagnosis of cancer in a companion animal could be considered a death sentence, but today, drugs designed for use in human patients offer a good quality of life and extended survival for many veterinary cancer patients. Often, the key to the success of that treatment is compounding, in which doses of manufactured drugs that would prove toxic to a cat or dog are reformulated into appropriate strenths or concentrations that provide beneficial therapy. In this article, two case reports describe the use of anticancer agents in dogs, and formulations for the compounding of several antineoplastic agents for veterinary patients are presented.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052269336

Download citation: RISBibTeXText

PMID: 23969962


Related references

Compounding prokinetic medications for companion animals. International Journal of Pharmaceutical Compounding 16(4): 276-286, 2012

Compounding for behavior problems in companion animals. International Journal of Pharmaceutical Compounding 9(3): 185-192, 2005

Pancreatic Ascites: Study of Therapeutic Options by Analysis of Case Reports and Case Series Between the Years 1975 and 2000. The American Journal of Gastroenterology 98(3): 568-577, 2003

Pancreatic ascites: Study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000. American Journal of Gastroenterology 98(3 Suppl.): 568-577, 2003

Review OTC options for managing dental health in companion animals. Proceedings of the North American Veterinary Conference6(16): 163-165, 2002

Ambitious plan for sector companion animals. Establishment Foundation Vaccination Companion Animals. Tijdschrift Voor Diergeneeskunde 122(17): 489-491, 1998

COMPANION ANIMALS SYMPOSIUM: Companion animals and sustainability: Today's impact on the future. Journal of Animal Science 93(3): 821-822, 2015

Companion Animals Symposium: Environmental enrichment for companion, exotic, and laboratory animals. Journal of Animal Science 89(12): 4227-4238, 2012

Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health. Epidemiology and Infection 138(5): 626-644, 2010

Compounding for pediatric patients: case reports and formulations. International Journal of Pharmaceutical Compounding 13(1): 6-12, 2009

Case reports: compounding to relieve arthritis pain. International Journal of Pharmaceutical Compounding 12(6): 498-504, 2008

Therapeutic use of fish oils in companion animals. Journal of the American Veterinary Medical Association 239(11): 1441-1451, 2012

The therapeutic functions of companion animals in infertility. Holistic Nursing Practice 5(2): 6-10, 1991

Therapeutic use of companion animals in health care. Image--the Journal of Nursing Scholarship 29(3): 249-254, 1997

The occurrence of zearalenone and its derivatives in standard and therapeutic feeds for companion animals. Polish Journal of Veterinary Sciences 7(4): 289-293, 2005